Low Float (Nasdaq: INBS) Has Multiple Triggered Technical Indicators (Strong Analyst Target)

*Sponsored

July 22nd

Greetings, Friend!

This just in... There's a past champ back on radar.

Brought into focus back a couple months back, it has since popped from a May 13th open of $1.28 to a high of $2.23 this week.

That run of approximately 74% showed how explosive this under-the-radar Nasdaq profile can be.

And with a low float of fewer than 7Mn shares, a $12 analyst target suggesting over 425% potential upside from Tuesday's close, and several triggered technical indicators, Wall Street's attention may start coming its way.

Consider taking a look at: Intelligent Bio Solutions Inc. (Nasdaq: INBS)

Intelligent Bio Solutions Inc. is rapidly emerging as a leader in the medical technology sector, pioneering non-invasive, real-time point-of-care testing solutions that are reshaping how drug screening and diagnostics are conducted worldwide.

With a focus on pain-free, accessible, and accurate testing, the company is positioned at the forefront of a global movement toward more humane and efficient healthcare technologies.

Company Overview

Founded in 2016 and headquartered in New York, Intelligent Bio Solutions Inc. is committed to leveraging advanced technology to develop transformative solutions that improve quality of life.

The company’s mission is to redefine the approach to testing by delivering pain-free, accessible solutions that drive transformative change across healthcare and workplace safety.

Core Technologies and Products

Intelligent Fingerprinting Drug Testing Solution

At the heart of INBS’s innovation is the Intelligent Fingerprinting Drug Testing Solution.

This system utilizes a patented technology that analyzes sweat collected from the fingertips to detect recent drug use-including cann-a-bis, co-caine, o-piate-s, and me-thamp-heta-mine-within the preceding 16–24 hours.

The process is non-invasive, requiring less than a minute for sample collection and delivering results in under ten minutes.

Key advantages include:

Dignified, Non-Invasive Collection: No need for blood, urine, or saliva samples, reducing discomfort and privacy concerns.

Rapid Results: Enables timely decision-making in workplace, clinical, and law enforcement settings.

Portability and Ease of Use: Designed for use in the field, workplaces, and clinics, with minimal training required.

Hygienic and Cost-Effective: Reduces biohazard risks and maintenance costs, with annual calibration sufficing for ongoing use.

Regulatory Milestones And U.S. Market Entry

A significant milestone was achieved with the submission of the FDA 510(k) pre-market notification for the Intelligent Fingerprinting Drug Screening System in December 2024.

The company’s clinical studies have demonstrated high sensitivity, specificity, and usability, with performance data showing 94.1% accuracy and pharmacokinetic studies confirming the reliability of fingerprint sweat as a matrix for drug detection.

INBS is on track for a planned expansion into the multi-Bn dollar U.S. market in 2025, targeting a region that accounts for approximately 28% of the global drug screening market.

The rising rates of drug positivity in the U.S. workforce-particularly in safety-sensitive industries-underscore the urgent need for effective, rapid, and non-invasive testing solutions like those offered by INBS.

Intellectual Property and Competitive Position

INBS’s technology is protected by a robust intellectual property portfolio, including six U.S. patents covering the lateral flow test strip, sample collection cartridge, cartridge housing, and buffer clip design.

This IP protection strengthens the company’s competitive position as it prepares for broader commercialization and future product development.

Market Opp. And Future Outlook

Why Take A Closer Look?

Intelligent Bio Solutions Inc. stands out for several compelling reasons:

Innovative, Patented Technology: Non-invasive, rapid, and highly accurate testing solutions with strong IP protection.

Proven Market Acceptance: Operational in 19 countries with a growing base of over 450 customer accounts.

Strong Financial Trajectory: Demonstrated revenue and margin growth, with a scalable, recurring revenue model.

Strategic Global Expansion: Active in high-growth markets and sectors, with multilingual capabilities and key partnerships.

Clear Path to U.S. Market: On track for potential FDA clearance and entry into the world’s largest drug screening market in 2025.

Vision for Broader Diagnostics: Versatile biosensor platform poised for future applications in clinical diagnostics.

-----

Four (Nasdaq: INBS) Potential Catalysts To Consider

#1. A Low Float - INBS has a float of roughly 6.19Mn shares.

This means volatility potential may be heightened on a daily basis.

#2. An Analyst $12 Target - As of July 22nd, Ladenburg Thalmann Co. Inc. was reporting a $12 target on INBS.

From its closing valuation on Tuesday, that target is suggesting INBS to have over 425% potential upside.

#3. Intelligent Bio Solutions Expands Global Reach With SmarTest Patch Intelligent Bio Solutions Inc. announced a new global distribution agreement with SMARTOX to deliver its SmarTest Patch drug detection product to markets outside the U.S. and Canada.

This expands INBS’s portfolio with continuous, sweat-based drug detection, enhancing its global leadership in non-invasive testing. The partnership supports INBS’s international growth, adds a new revenue stream, and strengthens opp's in the justice and rehabilitation sectors.

FDA clearance remains a priority in its U.S. expansion strategy.

#4. Multiple Bullish Technical Indicators - At close on Tuesday, Barchart was reporting several technicals to be triggered across the short, medium, and long term.

In fact, the website shares that a total of 12 technical indicators are currently triggered.

On top of that, Barchart's composite "Trend Seeker" indicators is also triggered.

-----

Intelligent Bio Solutions Inc. (Nasdaq: INBS) is not just a company to watch-it is a transformative force in the medical technology landscape, delivering solutions that meet urgent global needs for rapid, reliable, and dignified testing.

Coverage is officially reinitiated on Intelligent Bio Solutions Inc. (Nasdaq: INBS). Keep an eye out for updates soon.

All the best,

Dane James

Editor Market Pulse Today

Sources:

INBS Website

INBS Presentation

(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)

*MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.

Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 07/22/2025 and ending on 07/23/2025 to publicly disseminate information about (INBS:US) via digital communications. Under this agreement, Thousand Sun Media LLC has been paid five thousand USD ("Funds"). To date, including under the previously described agreement, Thousand Sun Media LLC has been paid ten thousand USD ("Funds"). These Funds were part of the funds that TD Media LLC received from a third party who did not receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.

Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (INBS:US).

Please see important disclosure information here: https://marketpulsetoday.com/disclosure/inbs-3k8kx/#details

Low Float (Nasdaq: INBS) Has Multiple Triggered Technical Indicators (Strong Analyst Target)

0 Response to "Low Float (Nasdaq: INBS) Has Multiple Triggered Technical Indicators (Strong Analyst Target)"

Post a Comment